Placeholder
Uncategorized

test product

January 17, 2018

  • test product

  • Biopharma (by disease)

    Valeant Pharmaceuticals Intl, Inc. (VRX)

    January 3, 2018

    IDP-118 to be the next potential product in Psoriasis pipeline for VRX

  • Valeant Pharmaceuticals Intl, Inc. (VRX)

  • Healthcare

    Cigna Corporation (CI)

    January 2, 2018

    Steady growth in revenues driven by increase in premiums and fees

  • Cigna Corporation (CI)

  • Life Science

    Becton, Dickinson and Co. (BDX)

    January 2, 2018

    New product launches motivate revenues across both segments

  • Becton, Dickinson and Co. (BDX)

  • Life Science

    Agilent Technologies Inc (A)

    January 2, 2018

    Stands firmly with a strong foundation and a winning growth strategy

  • Agilent Technologies Inc (A)

  • Life Science

    Sanofi S.A. (SNY)

    December 29, 2017

    U.S. Dupixent launch performing ahead of its expectations

  • Sanofi S.A. (SNY)

  • Life Science

    Pfizer Inc (PFE)

    December 20, 2017

    Margins continue to increase in double digits with decreased costs

  • Pfizer Inc (PFE)

  • Uncategorized

    HP Inc (HPQ)

    December 19, 2017

    Strong FY17 performance but concerns persist on future growth

  • HP Inc (HPQ)

  • Life Science

    Boston Scientific Corporation (BSX)

    December 18, 2017

    Single-shot pulmonary vein isolation ablation market to be a blockbuster for BSX

  • Boston Scientific Corporation (BSX)